Literature DB >> 4018265

Bile acid binding in plasma: the importance of lipoproteins.

G Salvioli, R Lugli, J M Pradelli, G Gigliotti.   

Abstract

Bile acid (BA) hydrophobicity, evaluated by the octanol-water partition coefficient, decreases along the series deoxycholic acid-chenodeoxy cholic acid-hyodeoxycholic acid-ursodeoxycholic acid-cholic acid (CA)-ursocholic acid (UCA). In vitro experiments carried out using dialysis techniques (to determine the maximum BA binding) and ultrafiltration of plasma pre-incubated with 0.1 mM BA (to assess the distribution of BA between the different lipoprotein fractions) showed that the maximum binding of BA to plasma and lipoproteins follows the same order of hydrophobicity. The fraction not bound to proteins, greater with the hydrophilic BA (UCA and CA), is distributed in the lipoprotein fractions and in particular in high density lipoproteins.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4018265     DOI: 10.1016/0014-5793(85)81257-6

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  8 in total

Review 1.  Physiological and molecular biochemical mechanisms of bile formation.

Authors:  Vasiliy Ivanovich Reshetnyak
Journal:  World J Gastroenterol       Date:  2013-11-14       Impact factor: 5.742

Review 2.  An updated review on drug-induced cholestasis: mechanisms and investigation of physicochemical properties and pharmacokinetic parameters.

Authors:  Kyunghee Yang; Kathleen Köck; Alexander Sedykh; Alexander Tropsha; Kim L R Brouwer
Journal:  J Pharm Sci       Date:  2013-05-07       Impact factor: 3.534

3.  Studies on the origin of biliary phospholipid. Effect of dehydrocholic acid and cholic acid infusions on hepatic and biliary phospholipids.

Authors:  F Chanussot; H Lafont; J Hauton; B Tuchweber; I Yousef
Journal:  Biochem J       Date:  1990-09-15       Impact factor: 3.857

4.  Design and characterization of a novel fluorinated magnetic resonance imaging agent for functional analysis of bile Acid transporter activity.

Authors:  Diana Vivian; Kunrong Cheng; Sandeep Khurana; Su Xu; Valerie Whiterock; Drew Witter; Kimberley A Lentz; Kenneth S Santone; Jean-Pierre Raufman; James E Polli
Journal:  Pharm Res       Date:  2013-01-15       Impact factor: 4.200

5.  Interaction of potentially toxic bile acids with human plasma proteins: binding of lithocholic (3 alpha-hydroxy-5 beta-cholan-24-oic) acid to lipoproteins and albumin.

Authors:  M Malavolti; H Fromm; S Ceryak; K L Shehan
Journal:  Lipids       Date:  1989-07       Impact factor: 1.880

6.  Influence of human serum albumin on the bile acid-mediated inhibition of liver microsomal type 1 11β-hydroxysteroid dehydrogenase.

Authors:  Yorio Maeda; Mayumi Funagayama; Akio Shinohara; Chihiro Koshimoto; Hidemi Furusawa; Hiroshi Nakahara; Yukiko Yamaguchi; Tomokazu Saitoh; Takashi Yamamoto; Kansei Komaki
Journal:  J Physiol Biochem       Date:  2014-08-10       Impact factor: 4.158

7.  Effect of crilvastatin, a new cholesterol lowering agent, on unesterified LDL-cholesterol metabolism into bile salts by rat isolated hepatocytes.

Authors:  T Clerc; V Sbarra; N Diaconescu; H Lafont; G Jadot; C Laruelle; F Chanussot
Journal:  Br J Pharmacol       Date:  1995-02       Impact factor: 8.739

8.  Model-Based Prediction of Plasma Concentration and Enterohepatic Circulation of Total Bile Acids in Humans.

Authors:  Benjamin Guiastrennec; David P Sonne; Martin Bergstrand; Tina Vilsbøll; Filip K Knop; Mats O Karlsson
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2018-08-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.